Zhitong Finance App News, Cathay Biotech (688065.SH) issued an announcement. On October 16, 2024, the company's board of directors received a “Letter from Cathay Industrial Biotech Ltd.” (hereinafter referred to as the “Controlling Shareholder” or “CIB”), a “Proposal to Repurchase the Company's Shares” by Shanghai Kaisai Biotechnology Co., Ltd. The controlling shareholder proposed that the company use its own funds to repurchase part of the RMB common stock (A share) shares already issued by the company through centralized bidding transactions through the Shanghai Stock Exchange trading system. The total repurchase capital is not less than 10 million yuan, not more than 20 million yuan. The repurchase shares will be used for employee stock ownership plans or equity incentives at an appropriate time in the future.

Zhitong Finance App News, Cathay Biotech (688065.SH) issued an announcement. On October 16, 2024, the company's board of directors received a “Letter from Cathay Industrial Biotech Ltd.” (hereinafter referred to as the “Controlling Shareholder” or “CIB”), a “Proposal to Repurchase the Company's Shares” by Shanghai Kaisai Biotechnology Co., Ltd. The controlling shareholder proposed that the company use its own funds to repurchase part of the RMB common stock (A share) shares already issued by the company through centralized bidding transactions through the Shanghai Stock Exchange trading system. The total repurchase capital is not less than 10 million yuan, not more than 20 million yuan. The repurchase shares will be used for employee stock ownership plans or equity incentives at an appropriate time in the future.